The selective angiotensin AT 1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats

By Polidori C.   Ciccocioppo R.   Pompei P.   Cirillo R.   Massi M.  

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs

By Shibasaki M.   Fujimori A.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 175-184

Elsevier

Access to resources Recommend Favorite

Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension: A Double-Blind, Placebo-Controlled, Dose-Titration Study

By Guthrie R.  

Clinical Drug Investigation, Vol. 15, Iss. 3, 1998-03 ,pp. : 217-227

Adis International

Access to resources Recommend Favorite

Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives

By Nicolai E.   Cure G.   Goyard J.   Kirchner M.   Teulon J.   Versigny A.   Cazes M.   Virone-Oddos A.   Caussade F.   Cloarec A.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 5, 1995-01 ,pp. : 365-375

Elsevier

Access to resources Recommend Favorite

Radiosynthesis of [tetrazoyl- 11 C]irbesartan, a non-peptidic angiotensin II antagonist

By Ponchant M.   Demphel S.   Hinnen F.   Crouzel C.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 9, 1997-09 ,pp. : 747-752

Elsevier

Access to resources Recommend Favorite